HEALTH OF WOMAN. 2016.3(109):120–122; doi 10.15574/HW.2016.109.119 
 

Modern aspects of hiperandrogenic syndrome in reproductive aged women 
 

Achundova N. E.

Azerbaijan Medical University, Baku 
 

The objective: the aim of investigation was shedy of canses of hyperandrogenic syndrome in reproductive agel women in Azerbaijan Repablic.

Patients and methods: 367 women with hyperandrogenism were examined AU women underwent clinical, hormonal, funksional, biochemic analyses.

Results. It was shown that causes of HA were polycystic ovary syndrome in 32.7% women, hyperprolactinemia in 18.5% of women and hypertireoz in 12.5%.

Conclusion. It was shown that there was a relatively decreased freguency of obesity (6.3%), hyperthiroidism (4.6%), hypogonadotropic hypogonadism (6.8%), hipergonadotropic hypogonadism (5.7%).

The freguency of medicamentouz HA (2.5%), adrenal pathology (3.5%), adrogen-secreting tumors of ovarian origin (1,9%) was considerably lower.

Key words: HA, PCOS, hyperprolactinemia, congenital adrenal hyperplasia, idiopatic hirsutism, hypo– and hyperthyroidism, medicamentouz HA.

REFERENCES

1. Badzhelan B, Goryachkina MV, Dzhobava EM, Dobrohotova YuE. 2008. Giperandrogeniya i akne v praktike ginekologa i dermatologa: voprosyi diagnostiki i terapii. RMZh. 16;1:54–56.

2. Gilyazutdinov IA, Gilyazutdinov ZSh, Bogolyubova IM. 2008. Neyroendokrinnaya patologiya v ginekologii i akusherstve. Rukovodstvo dlya vrachey, 2-e izd. M, MEDpress-inform:432.

3. Dedov II, Melnichenko GA. 2012. Endokrinologiya: natsionalnoe rukovodstvo. M, GEOTAR-Media:1072.

4. Ovsyannikova TV, Prilepskaya VN, Serov VN. 2008. Ginekologicheskaya endokrinologiya. 3-e izd. M, MEDpress-inform:528.

5. Rogovskaya SI, Telunts AV, Saveleva IS. 2002. Akne kak proyavlenie sindroma giperandrogenii: metodyi korrektsii. Provisorum 8:28–29.

6. Soboleva EL, Potin VV, Tarasova MA. 2007. Girsutizm: posobie dlya vrachey. SPb, Izd-vo N-L:52.

7. Tkachenko LV, Sviridova NI, Isaykin DN. 2007. Antiandrogennyie effektyi sovremennyih kontratseptivov. Reproduktivnoe zdorove zhenschin 9;6:1–2.

8. Bals-Pratsch M, Geneidy N, Gruber R, Aslanids C. 2007. PCO Syndrom-Genetische Polymorphismen und klinische Befunde. Am. J. Reproduktionsmed Endokrinol. 5:253–254.

9. Bals-Pratsch M, Seifert B, Ortmann O. 2009. Genetic Causes in Adrenal or Ovarian Hyperandrogenism in the Reproductive Years. Am. J. Reproduktionsmed. Endokrinol. 6;1:19–23.

10. Jones MR, Wilson SG, Mullin BH, Mead R. 2007. Polymorphism of the follistatin gene in polycystic ovary syndrome. Mol.Hum. Reprod. 13:237–241. http://dx.doi.org/10.1093/molehr/gal120; PMid:17284512

11. Karnath BM. 2008. Signs of Hyperandrogenism in Women. Am.J.Hospital Physician: 25–30.

12. Rege G, Rainey W. 2012. The steroid of metabolome of adrenarche. Am.J.of endocrinology. 214;2:133–143. http://dx.doi.org/10.1530/JOE-12-0183; PMid:22715193 PMCid:PMC4041616

13. Simoni M, Tempfer CB, Destenaves B, Fauser BC. 2008. Functional genetic polymorphisms and female reproductive disorders. Part I. Polycystic ovary syndrome and ovarian response. Am.J.Hum.Reprod.Update 14:459–484. http://dx.doi.org/10.1093/humupd/dmn024; PMid:18603647 PMCid:PMC2515090